If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraemar Shipping Regulatory News (BMS)

Share Price Information for Braemar Shipping (BMS)

Share Price is delayed by 15 minutes
Get Live Data
247.00    7.00 (2.92%)
Bid:
236.00
Ask:
247.00
Spread: 11.00 (4.661%)
Market Cap: £79.01m
BMS Live PriceLast checked at - London Stock Exchange

Intraday Braemar Shipping Share Chart

Director/PDMR Shareholding

20 Apr 2026 16:32

RNS Number : 1867B
Braemar PLC
20 April 2026
 

 

20 April 2026

BRAEMAR PLC

("Braemar" the "Company")

 

PDMR Share Dealing

 

Braemar Plc (LSE: BMS), a leading provider of expert investment, chartering and risk management advice to the shipping and energy markets, announces that on 17 April 2026, James Gundy, Group Chief Executive Officer, exercised 218,750 nil cost options ("Options") granted under the Company's Long Term Incentive Plan ("LTIP") as set out below:

 

LTIP award grant date

 

Vesting date

Two-year holding period end date

 

Number of Options exercised

24 July 2020

24 July 2023

24 July 2025

218,750

 

 

The 2020 LTIP award vested following the assessment of the applicable performance conditions which were disclosed in the 2023 remuneration report (page 83), this report is available on the Company's website at Financial Reports - Braemar.

 

The exercise of the Options under the LTIP, has been satisfied through the allocation of existing ordinary shares held by the Braemar Employee Share Ownership Plan; as such, no new ordinary shares have been issued. In order to cover tax and national insurance liabilities arising from the exercise of the Options, James Gundy sold 103,088 shares on 17 April 2026 and retained the balance of 115,662 shares.

Following the above transactions, James Gundy's total shareholding is now 1,139,695 (being 3.4% of the Company's issued share capital).

The notification set out below is provided in accordance with the requirements of the EU Market Abuse Regulation, which is part of UK law by virtue of the European Union (Withdrawal) Act 2018.

 

For further information, contact:

 

Braemar Plc

Tel: +44 (0)20 3142 4100

James Gundy, Group Chief Executive Officer

Grant Foley, Group Chief Financial & Operating Officer

Rebecca-Joy Wekwete, Company Secretary

Houston

Tel: +44 (0)20 4529 0549

Kate Hoare / Charlie Barker / Polly Clarke

Tel: +44 (0)77 3303 2695

braemar@houston.co.uk

Canaccord Genuity

Tel: +44 (0) 20 7523 8000

Adam James / Harry Rees

 

 

 

Details of the person discharging managerial responsibilities / person closely associated

Name

James Gundy

 

Reason for the notification

Position/status

Group Chief Executive Officer

 

Initial notification /Amendment

Initial

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 

 

Name

Braemar Plc

 

LEI

213800EV6IKTTHJ83C19

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted. 

 

Description of the financial instrument, type of instrument

 

Ordinary shares of 10 pence each

Identification code

 

GB0000600931

Nature of the transaction 

 

Exercise of Options granted under the Company's LTIP in 2020

Price(s) and volume(s)

Price: £0.00

 

Volume: 218,750

 

Aggregated information

 - Price

 

- Aggregated volume

 

 

Price: £0.00

 

Volume: 218,750

Date of the transaction

17 April 2026

 

Place of the transaction 

Exercise of Options occurred outside a trading venue

 

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted. 

 

Description of the financial instrument, type of instrument

 

Ordinary shares of 10 pence each

Identification code

 

GB0000600931

Nature of the transaction 

 

Sale of shares to cover tax and national insurance following exercise of Options granted under the Company's LTIP in 2020

 

Price(s) and volume(s)

Price: £2.202792

 

Volume: 103,088

 

Aggregated information

 - Price

 

- Aggregated volume

 

 

Price: £227,081.42

 

Volume: 103,088

Date of the transaction

17 April 2026

 

Place of the transaction 

London Stock Exchange (XLON)

 

 

 

Notes to Editors:

 

About Braemar Plc

Braemar provides expert investment, chartering, and risk management advice to the shipping and energy markets that enable its clients to secure sustainable returns and mitigate risk in the volatile world of shipping and energy. Our experienced brokers work in tandem with specialist professionals to form teams tailored to our customers' needs, and provide an integrated service supported by a collaborative culture.

 

Braemar joined the Official List of the London Stock Exchange in November 1997 and trades under the symbol BMS.

 

For more information, including our investor presentation, visit www.Braemar.com and follow Braemar on LinkedIn.

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFZGZDKGGGVZM
Date   Source Headline
31st Mar 20145:01 pmRNSTotal Voting Rights
20th Mar 20147:00 amRNSDisposal of Casbarian
28th Feb 20143:15 pmRNSTotal Voting Rights
31st Jan 20149:55 amRNSTotal Voting Rights
29th Jan 20146:12 pmRNSBlocklisting Interim Review
29th Jan 20146:09 pmRNSBlocklisting Interim Review
29th Jan 20146:05 pmRNSReplacement - Holding(s) in Company
28th Jan 20142:51 pmRNSHolding(s) in Company
17th Jan 20147:00 amRNSInterim management statement
2nd Dec 20134:53 pmRNSTotal Voting Rights
29th Oct 20137:00 amRNSCompany Secretary Change
29th Oct 20137:00 amRNSHalf Yearly Report
2nd Sep 20132:19 pmRNSTotal Voting Rights
30th Aug 20134:09 pmRNSNotice of Results
28th Aug 20139:53 amRNSBlocklisting Interim Review
28th Aug 20139:50 amRNSBlocklisting Interim Review
1st Aug 20132:26 pmRNSTotal Voting Rights
26th Jul 20139:17 amRNSDirector Declaration
24th Jun 20135:33 pmRNSReplacement - Result of AGM
20th Jun 20134:00 pmRNSResult of AGM
19th Jun 201312:00 pmRNSAGM Trading Update
23rd May 20139:10 amRNSPosting of Annual Report and Notice of AGM
14th May 20137:00 amRNSFinal Results
2nd May 201312:08 pmRNSTotal Voting Rights
26th Apr 20137:00 amRNSNotice of Results
18th Mar 20134:40 pmRNSSecond Price Monitoring Extn
18th Mar 20134:35 pmRNSPrice Monitoring Extension
1st Mar 20134:49 pmRNSTotal Voting Rights
4th Feb 20139:02 amRNSTotal Voting Rights
29th Jan 20134:40 pmRNSSecond Price Monitoring Extn
29th Jan 20134:35 pmRNSPrice Monitoring Extension
28th Jan 20133:38 pmRNSBlocklisting Interim Review
28th Jan 20133:36 pmRNSBlocklisting Interim Review
16th Jan 20137:00 amRNSInterim Management Statement
31st Oct 20127:00 amRNSDirector/PDMR Shareholding
30th Oct 20127:00 amRNSHalf Yearly Report
1st Oct 201211:12 amRNSDirectorate Change
31st Aug 20124:02 pmRNSTotal Voting Rights
31st Jul 20121:03 pmRNSBlocklisting Interim Review
31st Jul 201212:56 pmRNSBlocklisting Interim Review
31st Jul 201212:55 pmRNSBlocklisting Interim Review
23rd Jul 20122:45 pmRNSTotal Voting Rights
22nd Jun 20124:58 pmRNSDirector/PDMR Shareholding
21st Jun 201210:59 amRNSResult of General Meeting
20th Jun 20127:00 amRNSChanges to executive board and IMS
15th Jun 201210:11 amRNSAnnual Information Update
31st May 201210:23 amRNSTotal Voting Rights
30th May 20125:11 pmRNSAGM Notice
18th May 20123:14 pmRNSPosting of Annual Report and AGM notice
10th May 20123:26 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.